MedPath

Evaluation of the effect of melatonin in reducing migraine attacks in comparison with standard treatment in patients treated in Shahid Sadoughi Hospital in Yazd

Phase 2
Recruiting
Conditions
migraine headache.
Migraine
Registration Number
IRCT20240220061059N2
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

age over 18 years
all patients with migraine who referred to the neurology clinic of Shahid Sadoughi Hospital in Yazd

Exclusion Criteria

Lack of consent to enter the study
pregnancy
lactation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Migraine headache severity using two standard criteria. Timepoint: baseline and 12 weeks later. Method of measurement: Global assessment of migraine severity (GAMS) ? MEGSEV Criteria.
Secondary Outcome Measures
NameTimeMethod
The number of days the patient had a migraine attack in the last month. Timepoint: At the end of the first, second and third month. Method of measurement: Through the researcher's face-to-face meeting with the patient in the clinic or through the researcher's phone call with the patient, the researcher obtains information about the number of days the patient had migraine attacks in the last month and writes it down in the questionnaire.
© Copyright 2025. All Rights Reserved by MedPath